Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review

Date: September 20, 2016
Pages: 112
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A1CD28CAA41EN
Leaflet:

Download PDF Leaflet

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Abbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s drugs, diagnostic and nutritional products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories Key Recent Developments

Sep 08, 2016: Abbott Named Industry Leader For Responsible And Sustainable Business For Four Consecutive Years On The Dow Jones Sustainability Index
Aug 30, 2016: First randomized trial compares stenting techniques for coronary bifurcation
Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
Jul 18, 2016: Publication of HPTN 052 final results
Apr 21, 2016: Abbott Introduces New Services And Tools To Help Labs Deliver Greater Operational Productivity

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Abbott Laboratories - Key Facts
Abbott Laboratories - Key Employees
Abbott Laboratories - Key Employee Biographies
Abbott Laboratories - Major Products and Services
Abbott Laboratories - Medical Equipment Pipeline Products Data
Abbott Laboratories Pipeline Products by Equipment Type
Abbott Laboratories Pipeline Products by Development Stage
Abbott Laboratories - History
Abbott Laboratories - Company Statement
Abbott Laboratories - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Abbott Laboratories - Business Description
Business Description - Diagnostics
Diagnostics - Overview
Diagnostics - Financials
Business Description - Established Pharmaceutical Products
Established Pharmaceutical Products - Overview
Established Pharmaceutical Products - Financials
Business Description - Nutritionals
Nutritionals - Overview
Nutritionals - Financials
Business Description - Other Products
Other Products - Overview
Other Products - Financials
Business Description - Vascular
Vascular - Overview
Vascular - Financials
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - SWOT Analysis
SWOT Analysis - Overview
Abbott Laboratories - Strengths
Strength - Diagnostics Business
Strength - Improved Performance of Nutritionals Segment
Strength - Success in International Markets
Abbott Laboratories - Weaknesses
Weakness - Patent Infringement Concerns
Weakness - Safety Issues:/Product Defects
Abbott Laboratories - Opportunities
Opportunity - Growing IVD Market
Opportunity - Inorganic Growth Drivers: Acquisitions
Opportunity - New Product Launches
Opportunity - Pipeline Products
Abbott Laboratories - Threats
Threat - Competitive Environment
Threat - Integration of Acquisitions
Threat - Stringent Government Regulations
Abbott Laboratories - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Abbott Laboratories, Medical Equipment, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Medical Equipment, Deals By Type, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Abbott Laboratories, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Sep 08, 2016: Abbott Named Industry Leader For Responsible And Sustainable Business For Four Consecutive Years On The Dow Jones Sustainability Index
Aug 30, 2016: First randomized trial compares stenting techniques for coronary bifurcation
Aug 02, 2016: Abbott Unveils Alinity, Its Unified Family Of Innovative Next-Generation Diagnostics Systems
Jul 21, 2016: Abbott considers further expansion of Russian business
Jul 20, 2016: Abbott Reports Second-Quarter 2016 Results
Apr 21, 2016: Abbott Introduces New Services And Tools To Help Labs Deliver Greater Operational Productivity
Apr 20, 2016: Abbott Reports First-Quarter 2016 Results
Mar 15, 2016: Abbott's Absorb, the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Feb 26, 2016: Abbott Issues Voluntary Safety Notice on MitraClip Delivery System Deployment Process
Feb 16, 2016: Abbott Receives Approval In Australia For Freestyle Libre-The Revolutionary Glucose Monitoring System For People With Diabetes

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories Pipeline Products by Equipment Type
Abbott Laboratories Number of Pipeline Products by Development Stage
Abbott Laboratories Pipeline Products Summary by Development Stage
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Medical Equipment, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Medical Equipment, Deals By Type, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Abbott Laboratories Pipeline Products by Equipment Type
Abbott Laboratories Pipeline Products by Development Stage
Abbott Laboratories, Performance Chart (2011 - 2015)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Medical Equipment, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Medical Equipment, Deals by Type, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

UTAK Laboratories Inc.
Siemens Healthcare GmbH
PTC Therapeutics, Inc.
Minapharm Pharmaceuticals & Chemical Industries
Medtronic plc
Health Discovery Corporation
GlaxoSmithKline Plc
F. Hoffmann-La Roche Ltd.
Eli Lilly and Company
Edwards Lifesciences Corporation
Boston Scientific Corporation
Boehringer Ingelheim GmbH
Becton, Dickinson and Company
Beckman Coulter, Inc.
Bayer HealthCare AG
Allenex AB
Skip to top


Ask Your Question

Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: